0xbt

Digital healthcare company Pharmeasy on Friday introduced that it's going to acquire a controlling stake in diagnostic
chain Thyrocare for Rs 4,546 crore. API
Holdings, the mother or father of the unicorn Pharmeasy, Buy grifulvin v online and A Velumani, Buy kamagra gold online
Chairman and Managing Director Buy Zemyc online
of Thyrocare Applied sciences, have signed a definitive agreement for Buy Zemyc online the deal.
Under the transaction, Buy Zemyc online the
Delhi-primarily based company will purchase 66.1 per
cent stake in Thyrocare from Velumani and his associates at Rs 1,300 per share, in line with a press release.
The transaction, Buy Zemyc online which is critical
because an entrenched player is getting
acquired by a startup, will also see a subsidiary of API making
an open supply to amass an additional 26 per cent stake in the listed Thyrocare, the statement said.
Velumani can be individually acquiring a minority non-controlling stake of lower than 5 per cent
in API as a part of a series of equity investments by current and
new buyers of API. Shares of Thyrocare closed 6.23 per cent up at Rs
1,448.05 apiece on BSE on Friday. Buy Zemyc online